您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2019, Vol. 57 ›› Issue (9): 88-96.doi: 10.6040/j.issn.1671-7554.0.2019.790

• • 上一篇    

慢阻肺患者感染鲍曼不动杆菌危险因素及耐药性分析

张宁1,杨燕2,李锐2,殷运红2,李昊2,曲仪庆2   

  1. 1. 山东省胸科医院呼吸与危重症医学科一病区, 山东 济南 250013;2. 山东大学齐鲁医院呼吸与危重症医学科, 山东 济南 250012
  • 发布日期:2022-09-27
  • 通讯作者: 张宁. E-mail:zhangning7676@163.com; 曲仪庆. E-mail:quyiqing@sdu.edu.cn
  • 基金资助:
    山东省重点研发计划(2007GG3002008、2015GGH318002、2015GSF118064)

Analysis of risk factors and drug resistance of Acinetobacter baumannii in patients with chronic obstructive pulmonary disease

ZHANG Ning1, YANG Yan2, LI Rui2, YIN Yunhong2, LI Hao2, QU Yiqing2   

  1. 1. Department of Respiratory and Critical Care Medicine A Ward, Shandong Chest Hospital, Jinan 250013, Shandong, China;
    2. Department of Respiratory and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2022-09-27

PDF (PC)

154

摘要： 目的 探讨慢性阻塞性肺疾病(COPD)患者鲍曼不动杆菌(AB)感染的危险因素及耐药性,为COPD患者AB感染的防治提供理论依据。 方法 收集2012~2015年呼吸内科及RICU住院患者完整的临床资料,根据纳入排除标准选出308例痰培养结果为AB阳性的病例。对308例AB阳性病例及COPD合并AB阳性的91例病例进行耐药菌的筛选及耐药性测定分析。选取144例COPD患者中AB感染与AB未感染分别为72例进行病例-对照研究,采用二元Logistic 回归分析与AB感染有关联的危险性因素。 结果 (1)与AB感染有统计学意义关联的危险性因素,单因素分析包括年龄、近期住院史、糖皮质激素及抗生素使用史、侵入性操作、慢性基础疾病、肺功能分级、急性加重频率有关(P<0.05);多因素Logistic回归分析有统计学意义关联的危险性因素为:侵入性操作(OR=3.725,95%CI=2.642~9.534)、近期住院史(OR=3.417,95%CI=1.412~8.515)、肺功能分级(OR=2.835,95%CI=1.565~8.623)、糖皮质激素使用史(OR=2.815,95%CI=1.328~9.045)、慢性基础疾病(OR=2.136,95%CI=1.023~8.146)、抗生素使用史(OR=2.326,95%CI=1.145~7.134)、急性加重频率(OR=2.823,95%CI=1.012~9.853)、年龄(OR=1.756,95%CI=1.003~7.035);(2)住院AB患者耐药实验结果显示对头孢吡肟耐药率最高(79.2%),替加环素耐药率最低(20.1%);(3)COPD患者感染的AB对亚胺培南(86.8% vs 59.4%)、头孢吡肟(93.4% vs 73.2%)、左氧氟沙星(82.4% vs 57.6%)、头孢哌酮舒巴坦(49.4% vs 29.0%)、替加环素(27.5% vs 17.1%)的耐药率更高,差异有统计学意义(P<0.05)。 结论 合并慢性基础疾病、侵入性诊疗操作、近期住院史、糖皮质激素及抗生素使用史、肺功能分级等是COPD患者AB感染的独立危险因素;与非COPD的AB下呼吸道感染患者相比, COPD患者AB感染对临床常用抗菌药物耐药率更高 。

关键词: 慢性阻塞性肺疾病, 鲍曼不动杆菌, 耐药, 危险因素, 多因素Logistic 回归分析

Abstract: Objective To explore the risk factor of Acinetobacter baumannii(AB)infection and drug resistance in patients with chronic obstructive pulmonary disease(COPD)in order to provide a theoretical basis for treating AB infection in COPD patients. Methods The clinical data of inpatients treated during 2012 and 2015 were collected from departments of respiratory and respiratory intensive care unit, and 308 AB positive patients were selected according to the exclusion criteria. Drug-resistant bacteria and drug resistance were detected in 308 AB positive cases and 91 COPD cases with AB. A case control study was performed in 144 COPD patients, including 72 AB positive and 72 AB negative cases. 山 东 大 学 学 报 (医 学 版)57卷9期 -张宁,等.慢阻肺患者感染鲍曼不动杆菌危险因素及耐药性分析 \=- The risk factors associated with AB infection were determined with binary logistic regression analysis. Results (1) Single factor analysis showed that age, recent history of hospitalization, history of glucocorticoid and antibiotics use, invasive operations, chronic diseases, classification of lung function and frequency of exacerbations were statistically significant (P<0.05). Multivariate Logistic regression showed that invasive operation (OR=3.725, 95% CI=2.642-9.534), recent history of hospitalization (OR=3.417, 95%CI=1.412-8.515), classification of lung function (OR=2.835, 95%CI=1.012-9.853), history of glucocorticoid use (OR=2.815, 95%CI=1.328-9.045), chronic disease (OR=2.136, 95%CI=1.023-8.146), history of antibiotic use(OR=2.326, 95%CI=1.145-7.134), frequency of exacerbations (OR=2.823, 95%CI=1.012-9.853), age (OR=1.756, 95%CI=1.003-7.035) were independent risk factors of AB infection (P<0.05). (2) Drug resistance tests of AB positive patients showed that cefepime had the highest drug resistance rate(79.2%), while tegacycline had the lowest drug resistance rate(20.1%). (3) Compared to non-COPD patients, COPD patients with AB had higher resistance rates to imipenem(86.8% vs 59.4%), cefepime(93.4% vs 73.2%), levofloxacin(82.4% vs 57.6%), cefoperazone sulbactam(49.4% vs 29.0%)and tegacycline(27.5% vs 17.1%). The differences were statistically significant (P<0.05). Conclusion Chronic diseases, invasive operation, recent history of hospitalization, history of glucocorticoid and antibiotic use and classification of lung function are independent risk factors for COPD patients infected with AB. Compared with non-COPD patients with lower respiratory tract infection of AB, COPD patients with AB have higher resistance rate to common clinical antibiotics.

Key words: Chronic obstructive pulmonary disease, Acinetobacter baumannii, Drug resistance, Risk factors, Multivariate logistic regression analysis

中图分类号: 

  • R574
[1] Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: Multidrug-resistant Acinetbacter baumannii [J]. Nat Rev Microbiol, 2007, 5(12): 939-951.
[2] 刘又宁, 曹彬, 王辉, 等. 中国九城市成人医院获得性肺炎微生物与临床特点调查[J]. 中华结核和呼吸杂志, 2012, 35(4): 739.
[3] Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections [J]. Lancet Infect Dis, 2008, 8(12): 751-762.
[4] Zheng YL, Wan YF, Zhou LY, et a1. Risk factors and mortality of patients with nosocomial earbapenem-resistant Acinetobacter baumannii pneumonia [J]. Am J Infect Control, 2013, 41(7): 59-63.
[5] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华内科杂志, 2013, 46(3): 254-261.
[6] Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease[EB/OL].(2006-11-19)[2009-12] http://www.Goldcopd.com.
[7] MacIntyre N, Huang YC. Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease [J]. Proc Am Thorac Soc, 2008, 5(4): 530-535.
[8] 王冬梅. 慢性阻塞性肺疾病急性加重期痰培养及药敏结果分析[J]. 大家健康, 2015, 9(7): 49-50.
[9] Ye F, He LX, Cai BQ, et al. Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China [J]. Chin Med J(Engl), 2013, 126(12): 2207 -2214.
[10] Diaz E, Planas K, Rello J. Infection associated with the use of assisted-ventilation devices [J]. Enferm Infecc Microbiol Clin, 2008, 26(7): 465-470.
[11] 中华人民共和国卫生部.医院感染诊断标准(试行)[J]. 现代实用医学, 2003, 15(7): 460-465.
[12] 汪复, 张婴元.实用抗感染治疗学[M].北京: 人民卫生出版社, 2004: 7-8.
[13] Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen [J]. Clin Microbiol Rev, 2008, 21(3): 538-582.
[14] 陈佰义, 何礼贤, 胡必杰, 等. 中国AB感染诊治与防控专家共识[J]. 中华医学杂志, 2012, 92(2): 76-82.
[15] Xiao-Min X, You-Fen F, Wei-Yun F, et al. Antibiotic resistance determinants of a group of multidrug-resistant Acinetobacter baumannii in China[J]. J Antibiot(Tokyo), 2014, 67(6):439-444.
[16] 王辉, 俞云松, 王明贵, 等. 替加环素体外药敏试验操作规程专家共识[J]. 中华检验医学杂志, 2013, 36(7): 584-587.
[17] Levin AS. Multi-resistant Acinetobacter infections: A role for sulbactam combinations in overcoming an emerging worldwide problem [J]. Clin Microbiol Infect, 2002, 8(3): 144-153.
[18] 李春辉. 医疗机构耐药菌MDR、XDR、PD的国际标准化定义专家建议(草案)[J]. 中国感染控制杂志, 2011, 12(3): 238-240.
[19] 张辉, 张小江, 徐英春, 等. 2012年中国CHINET不动杆菌属细菌耐药性监测[J]. 中国感染与化疗杂志, 2014, 14(5): 392-397.
[20] 胡付品, 朱德妹, 汪复, 等. 2014年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志, 2015, 15(5): 401-410.
[21] 俞云松. 多药耐药AB-21世纪革兰阴性菌的“MRSA”[J]. 中华临床感染病杂志, 2009, 2(7): 65-68.
[22] Bacakoglu F, Korkmaz Ekren P, Ta?瘙塂bakan MS, et al. Multidrug-resistant acinetobacter baumannii infection in respiratory intensive care unit [J]. Mikrobiyol Bul, 2009, 43(4): 575-585.
[23] Wroblewska MM, Sawicka-Grzelak A, Marchel H, et al. Biofilm production by clinical strains of Acin, etobacter baumannii isolated from patients hospitalized in two tertiary care hospitals [J]. FEMS Immunol Med Microbiol, 2008, 53(1): 140-144.
[24] Munoz-Price LS, Carling P, Cleary T, et al. Control of a two-decade endemic situation with carbapenem-resistant Acinetobacter baumannii: electronic dissemination of a bundle of interventions [J]. Am J Infect Control, 2014, 42(5): 466-471.
[25] Parameswaran GI, Sethi S. Pseudomonas infection in chronic obstructive pulmonary disease [J]. Future Microbiol, 2012, 7(10): 1129-1132.
[26] Morgan DJ, Liang SY, Smith CL, et a1. Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers [J]. Infect Ctrl Hosp Epidemiol, 2010, 31(7): 716-721.
[27] Efrati S, Deutsch I, Antonelli M, et al. Vantilator-associated pneumonia: current status and future recommendations [J]. J Clin Monit Comput, 2010, 24(2): 161-168.
[28] Lee SO, Kim NJ, Choi SH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study [J]. Antimicrob Agents Chemother, 2004, 48(1): 224-228.
[29] Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy[J].Chest, 2007, 131(1): 9-19.
[30] Rumbo C, Gato E, Lopez M, et al. Contribution of efflux pumps,porins,and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii [J]. Antimicrob Agents Chemother, 2013, 57(11): 5247-5257.
[31] 习慧明, 徐英春, 朱德妹, 等. 2010年中国CHINETAB耐药性监测[J]. 中国感染与化疗杂志, 2012, 12(2): 98-104.
[32] 张辉, 张小江, 徐英春, 等. 2011年中国CHINET不动杆菌属细菌耐药性监测[J]. 中国感染与化疗杂志, 2013, 13(5): 342-348.
[33] Rodriguez-Hernandez MJ, Pachon J, Pichardo C,et al. Imipenem,doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia [J]. J Antimicrob Chemother, 2000, 45(4): 493-501.
[1] 葛丽娟 金瑞峰 王纪文 许新升 李癊. 多药耐药基因1 C1236T多态性与癫痫患者对药物反应性的相关性[J]. 山东大学学报(医学版), 2209, 47(6): 99-102.
[2] 姚雪,卢冉冉,孙淑玲,高翠平,肖茹,王书会. 风湿性心脏病患者瓣膜置换术后医院感染风险预测评分模型的构建[J]. 山东大学学报 (医学版), 2022, 60(6): 90-96.
[3] 杨丛品,罗卓野,许秀华,李爱民,郝桂敏. 河北省某医院体检3 512例育龄女性生育选择及压力现状[J]. 山东大学学报 (医学版), 2022, 60(4): 62-67.
[4] 吕岩红,张志勉. 2 809名体检人群中高血压与幽门螺杆菌感染的关联性[J]. 山东大学学报 (医学版), 2022, 60(2): 43-47.
[5] 李燕,刘静,李娟,杨秋红. 50例孕产妇血流感染临床特征及胎盘病理分析[J]. 山东大学学报 (医学版), 2022, 60(1): 48-54.
[6] 哈春芳,李茹月. 卵巢癌耐药机制与靶向治疗策略的研究进展[J]. 山东大学学报 (医学版), 2021, 59(9): 117-123.
[7] 鞠建华,杨镇业,李青连,韩亚楠,李艳青,乔伊君,杨虎,张华然. 微生物药物研究开发现状与思考[J]. 山东大学学报 (医学版), 2021, 59(9): 43-50,63.
[8] 陈丽宇,肖娟,吕仙忠,段宝敏,洪凡真. 影响孕产妇下肢深静脉血栓预后的危险因素分析[J]. 山东大学学报 (医学版), 2021, 59(7): 38-42.
[9] 司海朋,张文灿,李乐,周鑫. Kümmell's病的危险因素和诊治研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 25-32.
[10] 徐兵,李勇,刘明,刘永辉. 沉默PRRX1基因表达可增强前列腺癌耐药细胞株PC-3/DTX对多西他赛的敏感性[J]. 山东大学学报 (医学版), 2021, 59(6): 103-110.
[11] 丁菲,姜洁. 姜黄素对子宫内膜癌孕激素抵抗的影响[J]. 山东大学学报 (医学版), 2021, 59(4): 35-41.
[12] 王纬,王凤琴,韩艳丽. 腹腔镜下右附件囊肿剥除术后发生心脏骤停1例[J]. 山东大学学报 (医学版), 2021, 59(11): 123-124.
[13] 赵立红,赵书平,聂升刚,孙晶,姜同峰. 507例男性生殖道感染病原体分布及耐药特征[J]. 山东大学学报 (医学版), 2021, 59(1): 55-58.
[14] 孙胜房,马会力,贾竹亭,李民涛. 车祸所致880例四肢开放性损伤并发早期感染的危险性因素分析[J]. 山东大学学报 (医学版), 2021, 59(1): 72-77.
[15] 陈擎仪,张烜,王娟,孙继伟,曹丹凤, 曹枫林. 妊娠期女性自杀意念的危险因素及其累积效应[J]. 山东大学学报 (医学版), 2021, 59(1): 91-94.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发